Functional Components of the Rb/E2F and p53 Pathways
Functional Components of the Rb/E2F and p53 Pathways
批准号:
8331380
负责人:
JEFFREY T CHANG
金额:
$22.98万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2014-09-29
关键词:
AlgorithmsApoptosisAreaBinding SitesBiological ProcessCancer BiologyCell CycleCell Cycle RegulationCell LineCollectionComplexComputer SimulationComputing MethodologiesDNA DamageDataData SetDevelopmentDrug Delivery SystemsE2F transcription factorsEvolutionGene Expression ProfileGenomicsGoalsHumanIn VitroIndividualInvestigationKnowledgeLeadLinkMalignant NeoplasmsMeasuresMediatingMethodologyMethodsMitosisMolecularPathway interactionsPatternPhaseProcessPromoter RegionsProteinsPublic HealthRNA InterferenceRegulationRepressionResearchS PhaseSeriesSmall Interfering RNAStructureStructure-Activity RelationshipSystems BiologyTherapeuticTimeTranscription Regulatory ProteinTumor Suppressor ProteinsVariantWorkanti-cancer therapeuticanticancer researchbaseclinically significantdrug sensitivityinsightinterestknock-downnovelresponsetranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Normal function of the Rb/E2F tumor suppressor pathway is compromised in all human tumors. Therefore, its function and regulation are areas of critical importance and intense interest for cancer research. pRb controls the cell cycle transition from G1- to S-phase through its repression of the E2F transcription factors. The Rb/E2F pathway regulates a diverse set of activities, and an investigation into the functional components that comprise the pathway would provide valuable insight into the biology of cancer.
To obtain a deeper understanding of the Rb/E2F pathway, I propose to decompose the pathway into its
constituent functional components using a computational approach, and then to investigate the associations among the functions, regulatory mechanisms, and clinical significance of the pathway components. In addition, I will also elucidate the functional relationships between the intertwined Rb/E2F and p53 pathways, yielding novel insight into the complex interactions between these tumor suppressor pathways. To investigate these issues, I will leverage methods I previously developed to decompose pathways and to infer the transcriptional regulatory proteins that drive their expression. Thus, the goals of this proposal are: (1) to decompose the Rb/E2F pathway into a series of independently functional pathway components regulated by identifiable transcriptional regulatory proteins, (2) to evaluate the correspondence between the components of the Rb/E2F pathway and identified regulators of the cell cycle, and (3) to identify components that connect the intertwined Rb/E2F (cell cycle initiation) and p53 (apoptosis) pathways.
These studies would lead to the development of novel methodologies that provide the opportunity to obtain a deeper understanding of the precise components that effect pathway functions, and elucidate the functional connections among the interrelated pathways in a general cellular context, a goal of systems biology. Ultimately, the ability to characterize and measure individual facets of pathway activity will facilitate the development of ever more finely tuned personalized therapeutics.
RELEVANCE TO PUBLIC HEALTH
Rb is a tumor suppressor that is dysfunctional in all cancers, leading to a cascade of various poorly
understood activities brought about by the E2F proteins. I propose to develop computational methods to identify these activities and study them individually, instead of as a whole. I believe that this will lead to a deeper understanding of the function of this pathway, as well as the drugs that target it.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/srep02687
发表时间:
2013
期刊:
SCIENTIFIC REPORTS
影响因子:
4.6
作者:
[Taube, Joseph H., Malouf, Gabriel G., Lu, Emily, Sphyris, Nathalie, Vijay, Vidya, Ramachandran, Priyanka P., Ueno, Katumasa R., Gaur, Sanchaika, Nicoloso, Milena S., Rossi, Simona, Herschkowitz, Jason I., Rosen, Jeffrey M., Issa, Jean-Pierre J., Calin, George A., Chang, Jeffrey T., Mani, Sendurai A.]
通讯作者:
Mani, Sendurai A.
Biopython: freely available Python tools for computational molecular biology and bioinformatics.
Biopython:用于计算分子生物学和生物信息学的免费 Python 工具。
DOI:
10.1093/bioinformatics/btp163
发表时间:
2009-06-01
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
[Cock PJ, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, Friedberg I, Hamelryck T, Kauff F, Wilczynski B, de Hoon MJ]
通讯作者:
de Hoon MJ
Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness.
DOI:
10.1038/onc.2014.417
发表时间:
2015-09-03
期刊:
Oncogene
影响因子:
8
作者:
[]
通讯作者:
DOI:
10.1371/journal.pbio.1001744
发表时间:
2014-01
期刊:
PLoS biology
影响因子:
9.8
作者:
[Bild AH, Chang JT, Johnson WE, Piccolo SR]
通讯作者:
Piccolo SR
Core 2: Computational Core
-
批准号:10207527
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2017
-
负责人:JEFFREY T CHANG
-
依托单位:
Project 2: Targeting Cooperative Phenotypes Common in Spatial Heterogeneity
-
批准号:10207530
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2017
-
负责人:JEFFREY T CHANG
-
依托单位:
Functional Components of the Rb/E2F and p53 Pathways
-
批准号:8145250
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2010
-
负责人:JEFFREY T CHANG
-
依托单位:
Functional Components of the Rb/E2F and p53 Pathways
-
批准号:8136767
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2010
-
负责人:JEFFREY T CHANG
-
依托单位:
Functional Components of the Rb/E2F and p53 Pathways
-
批准号:7589237
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2008
-
负责人:JEFFREY T CHANG
-
依托单位:
Functional Components of the Rb/E2F and p53 Pathways
-
批准号:7689222
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2008
-
负责人:JEFFREY T CHANG
-
依托单位:
TIME COURSE RESPONSE TO RECOMBINANT HUMAN FSH ADMINISTRATION
-
批准号:6265187
-
项目类别:
-
资助金额:$1.15万
-
财政年份:1998
-
负责人:JEFFREY T CHANG
-
依托单位:
TIME COURSE RESPONSE TO RECOMBINANT HUMAN LH ADMINISTRATION
-
批准号:6265179
-
项目类别:
-
资助金额:$1.15万
-
财政年份:1998
-
负责人:JEFFREY T CHANG
-
依托单位:
INSULIN IN FSH INDUCED OVARIAN RESPONSE IN PCOS
-
批准号:6265199
-
项目类别:
-
资助金额:$1.15万
-
财政年份:1998
-
负责人:JEFFREY T CHANG
-
依托单位:
BIOLOGICAL RHYTHMS OF REPRODUCTIVE HORMONES AND NEUROTRANSMITTERS
-
批准号:6117885
-
项目类别:
-
资助金额:$1.46万
-
财政年份:1998
-
负责人:JEFFREY T CHANG
-
依托单位:
PCO MEASUREMENT OF RAS PROTEIN IN PCOS
-
批准号:6265182
-
项目类别:
-
资助金额:$1.15万
-
财政年份:1998
-
负责人:JEFFREY T CHANG
-
依托单位:
Core 2: Computational Core
-
批准号:9482414
-
项目类别:
-
资助金额:$17.63万
-
财政年份:--
-
负责人:JEFFREY T CHANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: